Drawing for VYNOVLI

USPTO serial 79199751

VYNOVLI

Reviewed by CopyMark Law Group

Reg. 5215876Status 709
Filing date
Status date
Registration date
Jun 6, 2017
Examiner
COLEMAN, CIMMERIAN
Law office
TMEG LAW OFFICE 102

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VYNOVLI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRALEIGH, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005[ Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; ] pharmaceutical preparations for use in ophthalmology [ ; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 1, 2024INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Sep 4, 2024INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 4, 2024INPCINVALIDATION PROCESSED—
Aug 23, 2024INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 22, 2023C71TCANCELLED SECTION 71—
Jun 6, 2022REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 30, 2018INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Oct 31, 2018INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Oct 31, 2018INPCINVALIDATION PROCESSED—
Oct 20, 2018INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 27, 2018LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Feb 20, 2018A7OKAMENDMENT UNDER SECTION 7 - PROCESSED—
Feb 20, 2018APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 28, 2017GPNXNOTIFICATION PROCESSED BY IB—
Jul 7, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 7, 2017FIMPFINAL DISPOSITION PROCESSED—
Jul 6, 2017GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Jul 5, 2017ES7RTEAS SECTION 7 REQUEST RECEIVED—
Jul 1, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 1, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 30, 2017LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Jun 6, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 21, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 17, 2017GPNXNOTIFICATION PROCESSED BY IB—
Mar 1, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 1, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 1, 2017NPUBNOTICE OF PUBLICATION—
Feb 8, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 8, 2017DOCKASSIGNED TO EXAMINER—
Jan 21, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 17, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 13, 2017LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jan 5, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance